Pfizer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
3,849.40
-0.3 (-0.01%)
BSENSE

Nov 20

BSE+NSE Vol: 14.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 11.28% vs 3.80% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 53.20% vs 2.33% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 5.51% vs 4.92% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 129.45% vs -30.81% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Pfizer With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
726.86
681.99
44.87
6.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
726.86
681.99
44.87
6.58%
Raw Material Cost
56.51
299.25
-242.74
-81.12%
Purchase of Finished goods
206.28
0.00
206.28
(Increase) / Decrease In Stocks
34.48
-56.39
90.87
161.15%
Employee Cost
91.43
69.61
21.82
31.35%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
76.96
104.33
-27.37
-26.23%
Total Expenditure (Excl Depreciation)
465.66
416.80
48.86
11.72%
Operating Profit (PBDIT) excl Other Income
261.20
265.19
-3.99
-1.50%
Other Income
47.33
19.92
27.41
137.60%
Operating Profit (PBDIT)
308.53
285.11
23.42
8.21%
Interest
3.35
1.31
2.04
155.73%
Exceptional Items
132.06
0.00
132.06
Gross Profit (PBDT)
437.24
283.80
153.44
54.07%
Depreciation
14.41
21.82
-7.41
-33.96%
Profit Before Tax
422.83
261.97
160.86
61.40%
Tax
109.58
65.23
44.35
67.99%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
313.25
196.75
116.50
59.21%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
313.25
196.75
116.50
59.21%
Equity Capital
45.75
24.55
21.20
86.35%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
68.47
16.03
52.44
327.14%
Diluted Earnings per share
68.47
15.98
52.49
328.47%
Operating Profit Margin (Excl OI)
35.94%
38.88%
0.00
-2.94%
Gross Profit Margin
60.15%
41.61%
0.00
18.54%
PAT Margin
43.10%
28.85%
0.00
14.25%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 726.86 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 11.28% vs 3.80% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 13.16% vs 9.13% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 313.25 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 53.20% vs 2.33% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 65.72% vs 19.37% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 261.20 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 5.51% vs 4.92% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 13.60% vs 21.50% in Sep 2025

Quarterly - Interest
Interest 3.35 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 129.45% vs -30.81% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 57.28% vs 1.43% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.94%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025